HIVWomen
Meeting category
Date(s)
26 Apr 2021 - 28 Apr 2021
Meeting type
Virtual Meeting
CME Credits
7
Organizer

International Workshop on HIV & Women 2021

Related Enduring Materials

Enduring Materials

Day 1 - Monday, 26 April 2021

Session 1 - COVID-19, HIV and Women -
COVID-19 and HIV and Women
Anna Maria Geretti, MD, PhD, FRCPath
University of Rome, Italy / King's College London, United Kingdom
COVID-19 and Pregnancy
Sigal Yawetz, MD
Harvard Medical School / Brigham and Women’s Hospital, United States
HIV and COVID-19 Vaccines
Fiona Burns, PhD, FRCP
Royal Free Hospital London, United Kingdom
Position Paper: Confinement: Women, HIV & Pregnancy During the 2020 COVID-19 lockdown in the UK
Fungai Murau, MCIM, MA
Independent Consultant (HIV), United Kingdom
Session 2 - Abstract-Driven Presentations: HIV & Women - General Topics -
Why Would I Need To? Australian Trans Women’s Awareness And Testing For HIV (#1)
Bella Bushby
Positive Life NSW, Australia
Meta-Analysis Of RCTs To Assess Weight Gain And Sex Differences With INSTI Or TAF Regimens In ARV Treatment Naïve Persons Living With HIV-1 Infection (#2)
Shuang Zhou
FDA, United States
Hormonal Contraception Is Associated With Increased Risk Of Cardiometabolic Disease In Women Living With HIV (#3)
Jamison Norwood
Vanderbilt University Medical Center, United States
HPV-Related Cancer Awareness Among Women And Trans And Gender Diverse People Living With HIV – A Community Survey (#4)
Bella Bushby
Positive Life Nsw, Australia

Day 2 - Tuesday, 27 April 2021

Session 3 - U=U implementation: How to Reach Women -
Criminalization. Update on Legal Aspects
Edwin Bernard
HIV Justice Network, the Netherlands
Michaela Clayton
HIV Justice Network, Namibia
Addressing Stigma and Discrimination to Advance U=U for Women
Kate Thomson
The Global Fund, Switzerland
How to Get More Women to Understand U=U Message
Silvia Petretti, MA
Positively UK, United Kingdom
Session 4 - Abstract-Driven Presentations: HIV & Pregnancy -
Angiopoietin 2 Levels Are Elevated In The 3rd Trimester In The Plasma Of Pregnant Women Living With HIV On PI-Based ART: A Potential Biomarker Of PI-Associated Increased Placental Angiogenesis (#5)
Caroline Dunk
Toronto General Research Institute, Univeristy Hospital Network, Canada
Patterns Of Changing Pregnancy Intentions Among Women Living With HIV In Canada (#6)
Lashanda Skerritt
McGill University, Canada
Peer Support For Achieving EMTCT (#7)
Clare Hofmeyr
Mothers2Mothers, South Africa
Breastfeeding And HIV In The U.S. And Canada: Centering Women’S Lived Experiences Into The Clinical, Research, And Policy Discussion (#8)
Krista Martel
The Well Project, United States
Session 5 - PrEP and Women -
PrEP in Young African Women: Early Lessons Learned
Connie Celum, MD, MPH
University of Washington, United States
Cabotegravir for Women: A Potential Game Changer
Nyaradzo Mavis Mgodi, MBChB, MMed
University of Zimbabwe Clinical Trials Research Centre, Zimbabwe
Community Perspective
Beauty Nerupfunde
University of Zimbabwe Clinical Trials Research Centre, Zimbabwe

Day 3 - Wednesday, 28 April 2021

Industry-Supported Satellite Symposium -
Boobs, Babies and Big Choices - Perspectives on Breastfeeding from Mums Living with HIV
Session 6 - Debate: Virtual Care Works Well For All Women With HIV -
Care Provider: For the Proposition
Justyna Kowalska, MD, PhD
Medical University of Warsaw, Poland
Care Provider: Against the Proposition
Laura Waters, MD, FRCP
Central & North West London NHS Foundation Trust, United Kingdom
Community Representative: For the Proposition
Susan Cole, FRSA
Global Network of People with HIV, United Kingdom
Community Representative: Against the Proposition
Cleopatra Machira
Cleopatra Machira
Pabaa Collections, Kenya
Session 7 - Social Protection and Mental Health -
Care Provider's Perspective
Shimu Khamlichi, PhD
Royal Free Hospital London, United Kingdom
Community Perspective
Dazon Dixon Diallo, DHL, MPH
SisterLove, United States
The Mental Health Of Women Aged 45-60 Living With HIV In England: A Latent Class Analysis Of The PRIME Study (#9)
Katharina Haag
University College London, United Kingdom
Hot Flashes And Cardiovascular Disease Risk Indices Among Women With HIV (#10)
Mabel Toribio
Massachusetts General Hospital, United States
Comorbidity Risk Scores And Immune Aging Markers In Women Over 45 Years Old Living With Or Without HIV In The Carma Cohort In British Columbia: A Preliminary Analysis (#11)
Tetiana Povshedna
University Of British Columbia, Canada
Progression Of Symptoms During The Menopause Transition In Women Living With HIV (#12)
Elizabeth King
Infectious Diseases, Canada
Overview
Image
HIV WOMEN
CME Accreditation
The International Workshop on HIV & Women 2021, Utrecht (livestream), Netherlands, 26/04/2021-28/04/2021 has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) with 7 European CME credits (ECMEC®s). Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.

Through an agreement between the Union Européenne des Médecins Spécialistes and the American Medical Association, physicians may convert EACCME® credits to an equivalent number of AMA PRA Category 1 CreditsTM. Information on the process to convert EACCME® credit to AMA credit can be found at www.ama-assn.org/education/earn-credit-participation-international-activities.

Live educational activities, occurring outside of Canada, recognised by the UEMS-EACCME® for ECMEC®s are deemed to be Accredited Group Learning Activities (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada.
Unique Features
- Three-day virtual meeting
- Invited lectures from international experts
- Interactive round-table discussions
- Ample time for discussion
Who Should Attend?
- Clinicians
- Researchers
- Academia
- Industry
- Government representatives
Meeting Objectives
The objectives of this workshop are to:

- Facilitate an unbiased and scientific knowledge exchange regarding HIV & Women, and encouraging early-career investigators to actively partake in the workshop;

- Summarize and promote the current state of the science regarding HIV and women and its successful translation and dissemination;

- Foster new and lasting cross-disciplinary partnerships and collaborations between researchers and HIV and women, in order to improve knowledge sharing, with the end goal of improving the health span of HIV-infected women.
Learning Objectives
After attending this workshop, participants will be able to:

- Integrate the latest scientific results into daily clinical care to improve the quality of life for women living with HIV;

- Have an understanding of the challenges and opportunities to guide women living with HIV through different life phases;

- Have an understanding of prevention strategies for women;

- Identify gaps in the field of HIV and women and develop new concepts for research and care strategies.

Practical Information 

Certificate of Attendance
A certificate of attendance will be sent to participants after the have attended the workshop and completed the post-meeting survey.
Language
The official language of the workshop is English.
Translation will not be provided.
Disclaimer
This workshop is intended for educational purposes only and aims to offer participants the opportunity to share information. The conference secretariat of this workshop, Virology Education, cannot accept any liability for the scientific content of the sessions or for any claims which may result from the use of information or publications from this workshop. Virology Education disclaims all liability for injuries or losses of whatever nature incurred by individuals attending the workshop.
Liability and Insurance
By registering for the workshop participants agree that the organizers do not accept responsibility for medical-, travel- or personal insurance. Participants are advised to take out their own insurance policies.
Photographs, Audio, and Video Recording
Photographs, audio, and video recordings are not permitted at the official workshop sessions. Only the official medical writer appointed by the organization may make recordings. All presentations will be posted here as soon as possible after the workshop is finished, provided the speaker has given permission to do so.
Committees
Organizing Committee

The members of the Organizing Committee are a group of carefully selected experts and inspirational leaders in their respective fields. They meet frequently to discuss the scientific program of the workshop, identify interesting topics and candidate speakers, and review all submitted abstracts.

Scientific Committee

The members of Scientific Committee are hand-picked by the Organizing Committee and the conference secretariat based on their significant contributions and commitment to the field. They assist the Organizing Committee by providing them with suggestions for speakers and topics. In addition, members of the Scientific Committee participate in reviewing submitted abstracts, and play an active role during the workshop as moderators and/or chairs of sessions.

  • Karoline Aebi-Popp, MD, MSc, University Hospital Bern, Switzerland
  • Dawn Averitt, The Well Project/WRI, United States
  • Olą Belyaeva, Eurasian Network of People who Use Drugs (ENPUD), EECA
  • Marina Bobkova, MD, Ivanovsky Institute of Virology, Russia
  • Claudia Cortes, MD, Universidad de Chile, Chile
  • Dazon Dixon Diallo, MPH, Sister Love, United States
  • Annette Haberl, MD, HIV CENTER University Hospital Frankfurt, Germany
  • Shirin Heidari, PhD, Graduate Institute of International and Development Studies, Switzerland
  • Miriam-Colette Kempf, MD, MPH, University of Alabama at Birmingham , United States
  • Justyna Kowalska, MD, Hospital for Infectious Diseases, Poland
  • Allen Kyendikuwa, BA, Uganda Youth Coalition on Adolescent SRHR and HIV (CYSRA), Uganda
  • Mona Loutfy, MD, FRCPC, MPH, Women's College Research Institute (Univ. Toronto), Canada
  • Mariana Mardarescu, MD, PhD, Institute for Infectious Disease Matei Bals, Romania
  • Catia Marzolini, PharmD, PhD, University Hospital Basel, Switzerland
  • Deborah Money, MD, MSc, University of British Columbia, Canada
  • Teresia Otieno, ATHENA Network, Namibia
  • Lena Serghides, PhD, University Health Network, Canada
  • William Short, MD, MPH, University of Pennsylvania, United States
  • Shema Tariq, PhD, University College London, United Kingdom
  • Patricia Vasquez, MD, Hospital San Juan de Dios, Chile
  • Marta Vasylyev, MD, Astar Medical Center, Ukraine
  • Markela Zanni, MD, MGH/Harvard Medical School, United States

Support
Titanium Level
Gilead Sciences
Gold Level
Endorsers
Language